Citius Oncology CTOR Insider Ownership

NASDAQ CTOR
$1.05 +0.02 (+1.94%)
At close: Sep 29, 2026 · 4:00 PM EDT

Insider Holdings by Owner

6.02Mn Shares

Insider Ownership Statistics

as of 30 Sep, 2026
Insider Ownership
5.67%
■0% pp QoQ
Shares Held by Insiders
6.12Mn
filed for Sep 2026
■0.00% QoQ
Shares Outstanding
107.89Mn
107,890,452 shares
Direct Holdings
6.02Mn
Indirect: 100.00K
Net Shares Traded (QoQ)
0
no net change in Sep 2026
Insiders Holding Shares
10
with Form 4 holdings on file

Shares Owned by Insiders

Shares held % of outstanding
Latest —
Average ownership —
Peak ownership —

Shares Purchased/Sold by Insiders

Bought Sold
Latest quarter —
Net over range —
Buying quarters —

Insider Ownership Summary

Quarter ending 30 Sep, 2026

As of September 29, 2026, the three largest insider holders of CTOR are Leonard L Mazur (Chief Executive Officer, 1.70Mn shares), Myron Z Holubiak (Secretary, 850.00K shares), Jaime Bartushak (Chief Financial Officer, 825.00K shares).

Form 4 Holdings

Insiders Holding CTOR

Insiders 10
Shares held 6.02Mn
Of outstanding 5.58%
# Insider Position Direct Indirect Total Share of Insiders Last Filed
1 Leonard L Mazur Chief Executive Officer 1,700,000 0 1,700,000 28.2% 01 Dec, 2025
2 Myron Z Holubiak Secretary 850,000 0 850,000 14.1% 01 Dec, 2025
3 Jaime Bartushak Chief Financial Officer 825,000 0 825,000 13.7% 01 Dec, 2025
4 Myron Czuczman Chief Medical Officer 825,000 0 825,000 13.7% 01 Dec, 2025
5 Joel David Mayersohn Director 321,228 0 321,228 5.3% 01 Dec, 2025
6 Robert Joseph Smith Director 300,000 0 300,000 5.0% 01 Dec, 2025
7 Dennis M Mcgrath Director 300,000 0 300,000 5.0% 01 Dec, 2025
8 Suren G Dutia Director 300,000 0 300,000 5.0% 01 Dec, 2025
9 Carol Webb Director 300,000 0 300,000 5.0% 01 Dec, 2025
10 Eugene Myron Holuka Director 300,000 0 300,000 5.0% 01 Dec, 2025

Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.

Form 4 Filings

45 Insider Transactions

Source SEC Form 4
Latest quarter Sep 2026
Download Data
Date Insider Position Transaction Shares Price Value Shares Held After Ownership
19 Sep, 2025 Eugene Myron Holuka Director Acquired A 300,000 $0.00 $0 300,000 Direct
19 Sep, 2025 Myron Czuczman Chief Medical Officer Acquired A 825,000 $0.00 $0 825,000 Direct
19 Sep, 2025 Joel David Mayersohn Director Acquired A 300,000 $0.00 $0 321,228 Direct
19 Sep, 2025 Suren G Dutia Director Acquired A 300,000 $0.00 $0 300,000 Direct
19 Sep, 2025 Dennis M Mcgrath Director Acquired A 300,000 $0.00 $0 300,000 Direct
19 Sep, 2025 Leonard L Mazur Chief Executive Officer Acquired A 1,700,000 $0.00 $0 1,700,000 Direct
19 Sep, 2025 Jaime Bartushak Chief Financial Officer Acquired A 825,000 $0.00 $0 825,000 Direct
19 Sep, 2025 Robert Joseph Smith Director Acquired A 300,000 $0.00 $0 300,000 Direct
19 Sep, 2025 Carol Webb Director Acquired A 300,000 $0.00 $0 300,000 Direct
19 Sep, 2025 Myron Z Holubiak Secretary Acquired A 850,000 $0.00 $0 850,000 Direct
19 Sep, 2025 Eugene Myron Holuka Director Acquired A 300,000 $0.00 $0 300,000 Direct
19 Sep, 2025 Myron Z Holubiak Secretary Acquired A 850,000 $0.00 $0 850,000 Direct
19 Sep, 2025 Joel David Mayersohn Director Acquired A 300,000 $0.00 $0 321,228 Direct
19 Sep, 2025 Carol Webb Director Acquired A 300,000 $0.00 $0 300,000 Direct
19 Sep, 2025 Suren G Dutia Director Acquired A 300,000 $0.00 $0 300,000 Direct
19 Sep, 2025 Robert Joseph Smith Director Acquired A 300,000 $0.00 $0 300,000 Direct
19 Sep, 2025 Dennis M Mcgrath Director Acquired A 300,000 $0.00 $0 300,000 Direct
19 Sep, 2025 Leonard L Mazur Chief Executive Officer Acquired A 1,700,000 $0.00 $0 1,700,000 Direct
19 Sep, 2025 Jaime Bartushak Chief Financial Officer Acquired A 825,000 $0.00 $0 825,000 Direct
19 Sep, 2025 Myron Czuczman Chief Medical Officer Acquired A 825,000 $0.00 $0 825,000 Direct